Tuesday, 02 January 2024 12:17 GMT
عربي


               US          Europe          Arab          Asia          Africa    
|      Politics          Economy     Oil&Energy         
                 Entertainment          Sport
Oncolytics Biotech Inc

Oncolytics Biotech Inc


2026-05-22 11:33:46
(MENAFN- Baystreet) 10:33 AM EST - Oncolytics Biotech Inc: Announces that translational data from the GOBLET and AWARE-1 trials will be presented at the 2026 American Society of Clinical Oncology Annual Meeting at McCormick Place, Chicago, Illinois, from May 29-June 2, 2026. Pelareorep is an investigational, systemically active immunotherapy that promotes potentially protective immune responses, including the upregulation of key inflammatory cytokines resulting in the formation of tertiary lymphoid structures and the expansion of tumor-infiltrating lymphocytes. Oncolytics Biotech Inc shares N are trading up one cent at $0.80.

Full Press Release:

MENAFN22052026000212011056ID1111156308



Baystreet.ca

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Tags

Label

Comments

No comment

Category

Date
Search